Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Mastrantonio, P.
Stefanelli, P.
Conti, F.
Cardines, R.
Sofia, T.
and
Salmaso, S.
1999.
Monitoring the genotype of meningococcal strains during an endemic period.
Clinical Microbiology and Infection,
Vol. 5,
Issue. 12,
p.
748.
Bramley, JC
Begg, NT
Booy, R
Buttery, J
Finn, A
Heath, PT
Jones, IG
Richmond, PC
Rosenstein, NE
and
Bramley, Claire
1999.
Cochrane Database of Systematic Reviews.
Ram, S
Mackinnon, F.G
Gulati, S
McQuillen, D.P
Vogel, U
Frosch, M
Elkins, C
Guttormsen, H.-K
Wetzler, L.M
Oppermann, M
Pangburn, M.K
and
Rice, P.A
1999.
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.
Molecular Immunology,
Vol. 36,
Issue. 13-14,
p.
915.
Cartwright, Keith A.V.
1999.
EARLY MANAGEMENT OF MENINGOCOCCAL DISEASE.
Infectious Disease Clinics of North America,
Vol. 13,
Issue. 3,
p.
661.
Bash, Margaret C.
Lynn, Freyja
Concepcion, Nelydia F.
Tappero, Jordan W.
Carlone, George M.
and
Frasch, Carl E.
2000.
Genetic and immunologic characterization of a novel serotype 4, 15 strain ofNeisseria meningitidis.
FEMS Immunology & Medical Microbiology,
Vol. 29,
Issue. 3,
p.
169.
Giroir, Brett P.
2000.
Meningococcemia as a model for testing the hypothesis of antisepsis therapies.
Critical Care Medicine,
Vol. 28,
Issue. Supplement,
p.
S57.
Skoczyńska, Anna
Kriz, Paula
Bossen Konradsen, Helle
and
Hryniewicz, Waleria
2000.
Characteristics of the Major Etiologic Agents of Bacterial Meningitis Isolated in Poland in 1997–1998.
Microbial Drug Resistance,
Vol. 6,
Issue. 2,
p.
147.
Vázquez, J.A.
2000.
Biología molecular e infección meningocócica: nuevas herramientas en el control de una vieja enfermedad.
Vacunas,
Vol. 1,
Issue. 3,
p.
99.
Choo, Sharon
Zuckerman, Jane
Goilav, Christian
Hatzmann, Eva
Everard, Jan
and
Finn, Adam
2000.
Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.
Vaccine,
Vol. 18,
Issue. 24,
p.
2686.
Clements, J. D.
Kolb-Mäurer, Annette
Unkmeir, Alexandra
Kämmerer, Ulrike
Hübner, Claudia
Leimbach, Thomas
Stade, Anne
Kämpgen, Eckhart
Frosch, Matthias
and
Dietrich, Guido
2001.
Interaction ofNeisseria meningitidiswith Human Dendritic Cells.
Infection and Immunity,
Vol. 69,
Issue. 11,
p.
6912.
RENNELS, MARGARET B.
EDWARDS, KATHRYN M.
KEYSERLING, HARRY L.
REISINGER, KEITH
BLATTER, MARK M.
QUATAERT, SALLY A.
MADORE, DACE V.
CHANG, IH
MALINOSKI, FRANK J.
HACKELL, JILL G.
and
PARADISO, PETER R.
2001.
Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.
The Pediatric Infectious Disease Journal,
Vol. 20,
Issue. 2,
p.
153.
Vázquez, Julio A.
2001.
The resistance of Neisseria meningitidis to the antimicrobial agents: an issue still in evolution.
Reviews in Medical Microbiology,
Vol. 12,
Issue. 1,
p.
39.
Rosenstein, Nancy E.
Perkins, Bradley A.
Stephens, David S.
Popovic, Tanja
and
Hughes, James M.
2001.
Meningococcal Disease.
New England Journal of Medicine,
Vol. 344,
Issue. 18,
p.
1378.
Parkkali, T
Käyhty, H
Lehtonen, H
Ruutu, T
Volin, L
Eskola, J
and
Ruutu, P
2001.
Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients.
Bone Marrow Transplantation,
Vol. 27,
Issue. 1,
p.
79.
Inmaculada Pereiró, Javier Díez-Dom
2001.
Epidemiological Pattern of Meningococcal Disease in Valencia, Spain. Impact of a Mass Immunization Campaign With Meningococcal C Polysaccharide Vaccine.
Scandinavian Journal of Infectious Diseases,
Vol. 33,
Issue. 8,
p.
581.
Čižman, Milan
Gubina, Marija
Paragi, Metka
Beovič, Bojana
and
Lešničar, Gorazd
2001.
Meningococcal disease in Slovenia (1993–1999): serogroups and susceptibility to antibiotics.
International Journal of Antimicrobial Agents,
Vol. 17,
Issue. 1,
p.
27.
Dull, Peter
and
Rosenstein, Nancy
2001.
Meningococcal Disease and Vaccines.
Pediatric Annals,
Vol. 30,
Issue. 6,
p.
358.
Bramley, J.Claire
Hall, Timothy
Finn, Adam
Buttery, Roger B
Elliman, David
Lockhart, Stephen
Borrow, Raymond
and
Jones, Ian G
2001.
Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age.
Vaccine,
Vol. 19,
Issue. 20-22,
p.
2924.
Morley, Sarah L.
and
Pollard, Andrew J.
2001.
Vaccine prevention of meningococcal disease, coming soon?.
Vaccine,
Vol. 20,
Issue. 5-6,
p.
666.
Kyaw, Moe H.
Clarke, Stuart C.
Christie, Peter
Jones, Ian G.
and
Campbell, Harry
2002.
Invasive Meningococcal Disease in Scotland, 1994 to 1999, with Emphasis on Group B Meningococcal Disease.
Journal of Clinical Microbiology,
Vol. 40,
Issue. 5,
p.
1834.